AngioDynamics grants sign-on stock awards to new CEO Eric Honroth

By Public Technologies
  • AngioDynamics granted sign-on restricted stock units to Eric Honroth on November 2, 2026, effective with his appointment as CEO.
  • The first award covers 62,928 shares, vesting in equal annual installments over four years, subject to continued service.
  • Performance-based restricted stock units cover 62,928 shares at target, with payouts ranging from 0% to 240% of target.
  • The performance award requires continued service through certification, with three-year targets covering revenue, adjusted EBITDA and relative total shareholder return.
  • Another 38,265 time-based restricted stock units vest equally on November 2, 2027, and November 2, 2028, subject to continued service.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AngioDynamics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261106038551) on November 06, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.